Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Medline makes and sells the everyday medical supplies hospitals and clinics run on, from gloves and gowns to scrubs and beds.
Medline is one of the biggest suppliers of the unglamorous stuff that keeps hospitals running: exam gloves, surgical gowns, wound dressings, syringes, bedpans, and the scrubs and gowns that nurses and doctors wear. It sells these products to hospitals, nursing homes, surgery centers, and other healthcare providers, mostly in the United States. If you have ever sat in an emergency room or watched a nurse snap on a pair of gloves, you have probably been in a room full of Medline products without knowing it.
The company does two things that reinforce each other. First, it manufactures a huge range of its own medical-surgical products, which means it controls the quality and the cost of the goods it sells. Second, it runs a supply-chain business: it warehouses products and delivers them to healthcare customers on a regular schedule, almost like a milk run for hospitals. That combination matters because hospitals hate running out of basics and hate managing dozens of separate suppliers. Medline offers one truck, one invoice, and one throat to choke, and it can lean on its own factories when a competitor's supply gets tight. The business is a scale game. Medline competes with giants like Cardinal Health, McKesson, and Owens & Minor, plus big distributors and low-cost manufacturers. Its edge comes from size — spreading factory, warehouse, and delivery costs across an enormous volume — and from sticky customer relationships, since switching suppliers means reworking how a hospital orders and stocks thousands of items. Medline went public on the Nasdaq Global Select Market in 2025 after decades as a family-run private company, a listing that gave the founding Mills family and its investors a public currency while keeping the family in control.
The money question is what Medline does with the cash it generates. It has spent heavily on new factories and distribution centers to make and move more of its own products, and it has used acquisitions to widen its catalog and reach. That spending is the bet: own more of the supply chain, so more of each hospital's spending lands in Medline's pocket instead of a competitor's. The risk is straightforward — hospitals are under pressure to cut costs, and a supplier that looks like a toll bridge on everyday goods is an easy target for price pushback. Medline's answer is to be so convenient and so reliable that customers would rather not shop around.
Saved answer · last researched 16 Nov 2026